Ariana Boswell

All articles by Ariana Boswell

• New gene variant linked to severe thrombocytopenia

  A recent case report describes a newborn with severe thrombocytopenia who was found to have a novel mutation in the MECOM gene.

• Expert panel develops guidelines for FNAIT management

  A group of obstetricians, pediatricians and other healthcare professionals reached a consensus on several aspects of FNAIT care.

• Review: Optimizing immunoglobulin therapy for immunodeficiency

  The increase in immunoglobulin administration for a wide range of conditions, including FNAIT, underscores the need to refine care guidelines.

• Review: Red blood cell production in infants differs from adults

  Infants have distinct hematological features compared to adults, which has implications for the treatment of diseases such as FNAIT.

• Platelet transfusions may be linked to a greater risk of bleeding events

  Critically ill children who receive a platelet transfusion before central line placement have an elevated risk of bleeding, a study found.

• Rallybio to present latest data on potential FNAIT treatment

  Rallybio Corporation will present on March 4, 2025 at the TD Cowen 45th Annual Health Care Conference in Boston, MA.

• Rare Disease Day: Why it matters and how to get involved

  Rare Disease Day 2025 aims to uplift the rare disease community and promote greater awareness.

• Johnson & Johnson reports nipocalimab’s therapeutic potential in FNAIT

  Preclinical data published by Johnson & Johnson support the therapeutic promise of nipocalimab in IgG-driven diseases such as FNAIT.

• Review: Mechanisms of thrombocytopenia in children

  A recent study summarizes various types of thrombocytopenia, including FNAIT, detailing their causes, clinical presentations and treatments.

• First patient dosed in phase 2 study of potential FNAIT treatment

  The first patient has been dosed in a Phase 2 study that will test the efficacy of a monoclonal antibody in pregnant women at risk of FNAIT.